OSSSC Nursing Disease Guide

Communicable · Very high priority

Dengue

Core disease facts with the linked government programme, prevention and treatment or cure reality.

TypeViral disease — caused by dengue virus.

Image-based identification

Aedes aegypti mosquito with white-banded legs
What to identifyAedes aegypti has conspicuous white markings and banded legs; it transmits dengue and chikungunya.Image credit: James Gathany, CDC — public domain

Government programmes, schemes and services

  • Programme: National Vector Borne Disease Control Programme (NVBDCP): Aims to reduce dengue illness and deaths through Aedes-breeding control, surveillance, case-management guidance and outbreak response.
  • Surveillance: IDSP–IHIP and dengue sentinel surveillance laboratories: Collect case information, confirm suspected dengue and give health teams early warning of clusters or outbreaks.

Prevention

  • Prevent: Weekly container emptying/scrubbing, source reduction, daytime bite protection, outbreak reporting

Treatment and cure reality

  • Treat: Usually self-limited; no routine specific antiviral cure. Careful fluids, monitoring, and treatment of shock/bleeding save lives.

Must remember

  • Serotypes: Four dengue-virus serotypes are classically recognised.
  • Vector: Mainly Aedes aegypti; bites mostly during the day.
  • Breeding: Artificial containers and clean stagnant water around homes; weekly emptying, scrubbing, drying, and covering are high-yield prevention actions.
  • Typical illness: Sudden fever, severe headache, retro-orbital pain, myalgia, arthralgia, nausea, rash, and leucopenia.
  • Danger period: Severe dengue often declares itself around defervescence, when fever falls—not necessarily at the highest temperature.
  • Warning signs: Severe abdominal pain, persistent vomiting, mucosal bleeding, fluid accumulation, lethargy/restlessness, liver enlargement, or rising haematocrit with a rapid platelet fall.
  • Early testing: Non-structural protein 1 antigen or nucleic-acid testing is most useful early; Immunoglobulin M becomes more useful later.
  • Platelets alone do not define severity: Shock, bleeding, plasma leakage, organ impairment, haematocrit trend, and clinical condition matter.
  • Treatment: No routine specific antiviral; careful oral/intravenous fluid management and monitoring are central.
  • Avoid: Aspirin and non-steroidal anti-inflammatory drugs because they increase bleeding risk; paracetamol is generally preferred for fever.
  • Antibiotics: Not useful for uncomplicated viral dengue.
  • Prevention: Source reduction, personal protection, community action, and prompt reporting of clusters.